|
시장보고서
상품코드
1787001
세계의 지혈 밸브 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 유형별, 용도별, 최종 용도별, 지역별 예측(2025-2034년)Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최근 조사에 따르면 세계의 지혈 밸브 시장 규모는 2034년까지 3억 3,988만 달러에 이를 전망입니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
지혈 밸브는 카테터 기반의 인터벤션 절차 중에 사용되는 의료기기로, 혈관 접근 부위로 장치를 통과하면서 출혈을 방지합니다. 일반적으로 가이드와이어나 카테터 등의 기구의 출입시에 지혈을 유지하는 씰 기구를 갖추고 있습니다.
헬스케어 인프라에 대한 세계 투자, 특히 신흥 시장에서는 고급 인터벤션 치료에 대한 액세스가 확대되고 있습니다. 정부와 민간 단체는 현대 장비를 갖춘 병원, 카테라보 및 진단센터에 대한 지출을 늘리고 있습니다. 지혈 밸브와 같은 신뢰할 수 있는 도구의 필요성은 대량의 카테터 기반 절차를 수행할 수 있는 시설에 대한 접근성이 향상됨에 따라 증가하고 있습니다. 또한 개발 도상 지역의 교육 프로그램과 워크숍은 첨단 인터벤션 인지도와 도입률을 높입니다. 이러한 건강 관리 인프라의 성장은 지혈 밸브 최종 사용자의 밑단을 넓혀 시장의 꾸준한 확대를 뒷받침하고 있습니다.
많은 제조업체들은 카테터 치료에 필요한 주사기, 도입기 및 기타 무균 장비를 포함한 완전한 인터벤셔널 프로시저 팩의 일부로 지혈 밸브를 제공합니다. 이러한 즉시 사용할 수있는 키트는 물류를 단순화하고 준비 시간을 단축하며 바쁜 임상 환경에서 워크 플로우의 효율성을 높입니다. 밸브를 프로시저 팩에 번들링하여 건강 관리 제공업체는 관리를 표준화하고 비용을 절감하며 일관된 장비를 사용하여 안전을 향상시킬 수 있습니다. 이러한 통합 접근법은 합리적인 솔루션을 원하는 병원 및 클리닉에 호소하고 지혈 밸브의 전반적인 판매를 밀어 올리고 편의성과 호환성으로 시장의 장기 성장을 지원합니다.
지혈 밸브 시장 보고서 하이라이트
2024년에는 병원 부문이 복잡한 인터벤셔널 기술의 주요 센터 역할을 하면서 가장 큰 점유율을 차지했습니다.
혈관성형술 부문은 폐색 또는 협착된 동맥의 치료에서 세계 사용률이 증가함에 따라 예측 기간 동안 큰 성장이 예상됩니다.
2024년에는 북미의 지혈 밸브 시장이 최대의 점유율을 차지했으며, 심혈관 처치가 많음, 첨단 헬스케어 인프라, 저침습 기술의 강력한 채용이 그 원동력이 되었습니다.
아시아태평양 지혈 밸브 시장은 건강 관리 투자 증가, 심혈관 질환 환자 증가, 낮은 침습 치료에 대한 접근의 확대로 큰 성장을 이루고 있습니다.
세계 주요 시장 기업으로는 Abbott, Antmed Corporation, Argon Medical Devices, B. Braun Melsungen AG, Beijing Demax Medical Technology Co., Boston Scientific Corporation, DeRoyal Industries, Inc., Freudenberg Medical, Lepu Medical Technology (Beijing) Co., Ltd., Merit Medical Systems, Nipro, SCW Medicath Ltd., Teleflex Incorporated, TERUMO CORPORATION 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 지혈 밸브 시장 인사이트
- 시장 현황
- 지혈 밸브 시장 역학
- 성장 촉진요인과 기회
- 심혈관 및 개입 처치 증가
- 저침습 수술의 성장
- 억제요인과 과제
- 높은 초기 비용
- 성장 촉진요인과 기회
- PESTEL 분석
- 지혈 밸브 시장 동향
- 밸류체인 분석
제5장 세계의 지혈 밸브 시장 : 유형별
- 주요 조사 결과
- 소개
- 지혈 밸브 Y 커넥터
- 더블 Y 커넥터 지혈 밸브
- 한 손 지혈 밸브
- 기타
제6장 세계의 지혈 밸브 시장 : 용도별
- 주요 조사 결과
- 소개
- 혈관 조영 검사
- 혈관성형술
제7장 세계의 지혈 밸브 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
- 외래수술센터(ASC)
- 기타
제8장 세계의 지혈 밸브 시장 : 지역별
- 주요 조사 결과
- 소개
- 지혈 밸브 시장 분석 : 지역별, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Abbott
- Antmed Corporation
- Argon Medical Devices
- B. Braun Melsungen AG
- Beijing Demax Medical Technology Co
- Boston Scientific Corporation
- DeRoyal Industries, Inc.
- Freudenberg Medical
- Lepu Medical Technology(Beijing) Co.,Ltd.
- Merit Medical Systems
- Nipro
- SCW Medicath Ltd
- Teleflex Incorporated
- TERUMO CORPORATION
The hemostasis valve market size is expected to reach USD 339.88 million by 2034, according to a new study by Polaris Market Research. The report "Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites. It typically features a sealing mechanism that maintains hemostasis when guidewires, catheters, or other devices are introduced or withdrawn.
Global investments in healthcare infrastructure, especially in emerging markets, are expanding access to advanced interventional procedures. Governments and private organizations are increasing spending on hospitals, cath labs, and diagnostic centers equipped with modern equipment. The need for reliable tools such as hemostasis valves grows with better access to facilities capable of performing high-volume catheter-based procedures. Moreover, training programs and workshops in developing regions are raising awareness and adoption of advanced interventional practices. This growth in healthcare infrastructure creates a broader base of end users for hemostasis valves, driving steady market expansion.
Many manufacturers offer hemostasis valves as part of complete interventional procedure packs, which include syringes, introducers, and other sterile tools required for catheterization. These ready-to-use kits simplify logistics, reduce preparation time, and enhance workflow efficiency in busy clinical environments. By bundling valves into procedure packs, healthcare providers can standardize care, reduce costs, and improve safety through consistent equipment usage. This integrated approach appeals to hospitals and clinics seeking streamlined solutions, boosting overall sales of hemostasis valves and supporting long-term market growth through convenience and compatibility.
Hemostasis Valve Market Report Highlights
In 2024, the hospital segment dominated with the largest share due to their role as primary centers for complex interventional procedures.
The angioplasty segment is expected to experience significant growth during the forecast period due to its rising global use in treating blocked or narrowed arteries.
In 2024, the North America hemostasis valve market dominated with the largest share, driven by a high volume of cardiovascular procedures, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies.
The Asia Pacific hemostasis valve market is experiencing significant growth due to increasing healthcare investments, rising cardiovascular disease cases, and expanding access to minimally invasive procedures.
A few global key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Beijing Demax Medical Technology Co.; Boston Scientific Corporation; DeRoyal Industries, Inc.; Freudenberg Medical; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.
Polaris Market Research has segmented the hemostasis valve market report on the basis of type, application, end use, and region:
By Type (Revenue - USD Million, 2020-2034)
Hemostasis Valve Y- Connectors
Double Y- Connector Hemostasis Valves
One- Handed Hemostasis Valves
Others
By Application (Revenue - USD Million, 2020-2034)
Angiography
Angioplasty
By End Use (Revenue - USD Million, 2020-2034)
Hospitals
Ambulatory Surgical Centers
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hemostasias Valve Market Insights
- 4.1. Hemostasias Valve Market - Market Snapshot
- 4.2. Hemostasias Valve Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Number of Cardiovascular and Interventional Procedures
- 4.2.1.2. Growth in Minimally Invasive Surgeries
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Cost
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hemostasias Valve Market Trends
- 4.6. Value Chain Analysis
5. Global Hemostasias Valve Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 5.3. Hemostasis Valve Y- Connectors
- 5.3.1. Global Hemostasias Valve Market, by Hemostasis Valve Y- Connectors, by Region, 2020-2034 (USD million)
- 5.4. Double Y- Connector Hemostasis Valves
- 5.4.1. Global Hemostasias Valve Market, by Double Y- Connector Hemostasis Valves, by Region, 2020-2034 (USD million)
- 5.5. One- Handed Hemostasis Valves
- 5.5.1. Global Hemostasias Valve Market, by One- Handed Hemostasis Valves, by Region, 2020-2034 (USD million)
- 5.6. Others
- 5.6.1. Global Hemostasias Valve Market, by Others, by Region, 2020-2034 (USD million)
6. Global Hemostasias Valve Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 6.3. Angiography
- 6.3.1. Global Hemostasias Valve Market, by Angiography, by Region, 2020-2034 (USD million)
- 6.4. Angioplasty
- 6.4.1. Global Hemostasias Valve Market, by Angioplasty, by Region, 2020-2034 (USD million)
7. Global Hemostasias Valve Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 7.3. Hospitals
- 7.3.1. Global Hemostasias Valve Market, by Hospitals, by Region, 2020-2034 (USD million)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. Global Hemostasias Valve Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD million)
- 7.5. Others
- 7.5.1. Global Hemostasias Valve Market, by Others, by Region, 2020-2034 (USD million)
8. Global Hemostasias Valve Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Hemostasias Valve Market Assessment, By Geography, 2020-2034 (USD million)
- 8.3. Hemostasias Valve Market - North America
- 8.3.1. North America: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.3.2. North America: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.3.3. North America: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.3.4. Hemostasias Valve Market - U.S.
- 8.3.4.1. U.S.: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.3.4.2. U.S.: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.3.4.3. U.S.: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.3.5. Hemostasias Valve Market - Canada
- 8.3.5.1. Canada: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.3.5.2. Canada: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.3.5.3. Canada: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4. Hemostasias Valve Market - Europe
- 8.4.1. Europe: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.2. Europe: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.3. Europe: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.4. Hemostasias Valve Market - UK
- 8.4.4.1. UK: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.4.2. UK: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.4.3. UK: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.5. Hemostasias Valve Market - France
- 8.4.5.1. France: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.5.2. France: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.5.3. France: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.6. Hemostasias Valve Market - Germany
- 8.4.6.1. Germany: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.6.2. Germany: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.6.3. Germany: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.7. Hemostasias Valve Market - Italy
- 8.4.7.1. Italy: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.7.2. Italy: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.7.3. Italy: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.8. Hemostasias Valve Market - Spain
- 8.4.8.1. Spain: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.8.2. Spain: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.8.3. Spain: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.9. Hemostasias Valve Market - Netherlands
- 8.4.9.1. Netherlands: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.9.2. Netherlands: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.9.3. Netherlands: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.10. Hemostasias Valve Market - Russia
- 8.4.10.1. Russia: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.10.2. Russia: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.10.3. Russia: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.4.11. Hemostasias Valve Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.4.11.2. Rest of Europe: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.4.11.3. Rest of Europe: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5. Hemostasias Valve Market - Asia Pacific
- 8.5.1. Asia Pacific: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.2. Asia Pacific: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.3. Asia Pacific: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.4. Hemostasias Valve Market - China
- 8.5.4.1. China: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.4.2. China: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.4.3. China: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.5. Hemostasias Valve Market - India
- 8.5.5.1. India: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.5.2. India: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.5.3. India: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.6. Hemostasias Valve Market - Malaysia
- 8.5.6.1. Malaysia: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.6.2. Malaysia: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.6.3. Malaysia: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.7. Hemostasias Valve Market - Japan
- 8.5.7.1. Japan: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.7.2. Japan: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.7.3. Japan: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.8. Hemostasias Valve Market - Indonesia
- 8.5.8.1. Indonesia: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.8.2. Indonesia: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.8.3. Indonesia: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.9. Hemostasias Valve Market - South Korea
- 8.5.9.1. South Korea: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.9.2. South Korea: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.9.3. South Korea: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.10. Hemostasias Valve Market - Australia
- 8.5.10.1. Australia: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.10.2. Australia: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.10.3. Australia: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.5.11. Hemostasias Valve Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.5.11.2. Rest of Asia Pacific: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.5.11.3. Rest of Asia Pacific: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6. Hemostasias Valve Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.2. Middle East & Africa: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.3. Middle East & Africa: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6.4. Hemostasias Valve Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.4.2. Saudi Arabia: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.4.3. Saudi Arabia: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6.5. Hemostasias Valve Market - UAE
- 8.6.5.1. UAE: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.5.2. UAE: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.5.3. UAE: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6.6. Hemostasias Valve Market - Israel
- 8.6.6.1. Israel: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.6.2. Israel: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.6.3. Israel: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6.7. Hemostasias Valve Market - South Africa
- 8.6.7.1. South Africa: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.7.2. South Africa: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.7.3. South Africa: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.6.8. Hemostasias Valve Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.6.8.2. Rest of Middle East & Africa: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.6.8.3. Rest of Middle East & Africa: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.7. Hemostasias Valve Market - Latin America
- 8.7.1. Latin America: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.7.2. Latin America: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.7.3. Latin America: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.7.4. Hemostasias Valve Market - Mexico
- 8.7.4.1. Mexico: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.7.4.2. Mexico: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.7.4.3. Mexico: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.7.5. Hemostasias Valve Market - Brazil
- 8.7.5.1. Brazil: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.7.5.2. Brazil: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.7.5.3. Brazil: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.7.6. Hemostasias Valve Market - Argentina
- 8.7.6.1. Argentina: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.7.6.2. Argentina: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.7.6.3. Argentina: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
- 8.7.7. Hemostasias Valve Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Hemostasias Valve Market, by Type, 2020-2034 (USD million)
- 8.7.7.2. Rest of Latin America: Hemostasias Valve Market, by Application, 2020-2034 (USD million)
- 8.7.7.3. Rest of Latin America: Hemostasias Valve Market, by End Use, 2020-2034 (USD million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Antmed Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Argon Medical Devices
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. B. Braun Melsungen AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Beijing Demax Medical Technology Co
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Boston Scientific Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. DeRoyal Industries, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Freudenberg Medical
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Lepu Medical Technology(Beijing)Co.,Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Merit Medical Systems
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Nipro
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. SCW Medicath Ltd
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Teleflex Incorporated
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. TERUMO CORPORATION
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
